LiveWire Ergogenics Purchases Two Self-Contained Cloning Pods to Add to its Coachella Cultivation and Nursery Operation
Anaheim, CA – April 12, 2018  - LiveWire Ergogenics, Inc. (OTC: LVVV), a company focused on the acquisition and licensing of special purpose real estate properties and management of legal, fully-controlled and self-contained turnkey production facilities for cannabis-based products and services, announced today that it has purchased two forty-foot-long fully automated and self-supporting cultivation pods. These pods, which are equipped with dedicated decontamination units, will be used for the cloning and production of teen plants for LiveWire’s high-quality genetics and pesticide-free cannabis strains. 
LiveWire’s new high-tech grow pods are currently being manufactured to the Company’s specifications. The end result will be a customized, cutting-edge production facility for LiveWire’s proprietary cloning process. As the premier nursery and clone provider for Coachella Brands, these pods should allow LiveWire to satisfy the demand from the Coachella property cultivators and other customers throughout California.

Bill Hodson, CEO of LiveWire, stated, “We have fast-tracked the installation of our first cloning facilities at our Coachella location in order to get production up and running as quickly as possible. These custom-built, self-contained production units will enable us to begin providing the many greenhouses planned for the Coachella property and in the vicinity with our high-quality products. With the use of these cloning pods we will be able to deliver our ‘7X Pure’ verified clones to growers in the required quantities, while Coachella Brands continues to construct additional growing facilities within the larger Coachella Brands facility.”  

The LiveWire cloning pods are currently being custom-built to the Company’s specifications by American Grow Products Inc to provide optimal performance. Every component used is state-of-the-art, to provide a suitable and fully-contained environment for the Company’s highly specialized cloning, growing, and production process.

The pods’ built-in components include: a commercial 5-ton Mega Split air conditioning system; a Quest Dehumidification system; Hurricane oscillating fans; carbon scrubbers; a CO2 system powered by Titan Controls, with Fuzzy Logic; and an irrigation system with an Eco Plus Chiller and Hydro-Logic RO System that can be set up either for recirculating or to drain to waste. All of these features will be supported by top-quality lighting, including Optic LEDs and AgroFlex Fluorescents. These pods are fully scalable to adjust to varying production output. Additional pods can be added as required to accommodate increased production capacity.
For more information about LiveWire Ergogenics, visit , follow LiveWire Ergogenics on Twitter @livewireLVVV, or download a research report at
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. (LVVV) specializes in identifying and monetizing current and future trends in the health and wellness industry. The Company is focused on acquiring and licensing specialized turnkey cannabis real estate locations and establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for human and veterinarian applications. This includes the cloning of cannabis strains to produce positive medicinal results, dosing verification of zero pesticide products for quality brands via its “7X Pure” Cannabis Dosing and Verification System, and development and licensing of high-quality cannabinoid-based products and services. The team at LiveWire Ergogenics has a passion for research and is committed to generating and implementing innovative ideas and producing high-quality products that satisfy an increasing demand in this fast-growing industry.

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals and commercialization of the Company’s products, or any of the Company’s other proposed products, systems or services. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and actual events may differ considerably. Factors that may cause actual results to differ materially from any projections may include, without limitation, the Company’s inability to obtain additional financing, delays in the development of its products, the impact of significant government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.

EquiNet, LLC
Toll free: 877-964-6463
Direct: 858-264-6500

1600 North Kraemer Blvd.
Anaheim, CA 92806
If you want to follow all other companies that we cover with more in depth research reports, go to our research site at to download the reports,
or visit for up to date news on the covered companies.
Please feel free to re-distribute the reports to your friends and colleagues.
We initiated coverage of LiveWire Ergogenics on August 16, 2017
StockWatchIndex and SWI Research (SWI) are not registered investment advisers and the information provided herein or any other SWI publication is not to be construed as personal financial advice, or a solicitation to buy or sell stock. SWI makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in its publications or on its web sites. Some of the published information has been provided by the companies covered, generated by publicly available sources, or what SWI deems to be reliable third party entities, but SWI does not guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or warrant any results from use of the information. Readers are encouraged to consult their personal financial adviser before making any decisions to buy, sell or hold any securities mentioned herein. StockWatchIndex is not responsible for any error, mistake or shortcoming that may be occasioned at the time of publishing of the information in this publication, any other SWI publication, or its web sites and is not obligated to update and/or correct information. No liability is accepted by StockWatchIndex whatsoever for any direct, indirect or consequential loss arising from the use of the information. SWI expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information provided. SWI has been compensated with five million restricted shares (subject to the restrictions of rule 144) by the Company  for the dissemination of this and future releases and  for continuing consulting and advisory services. The included information is subject to change without notice. Please visit!legal-ease/lmvw1   for a full text of our Disclaimer, Privacy policy and Terms of Use.